Mounjaro®
Starting from £179.99/mo
Start journey Learn moreTirzepatide begins acting in your body within hours of the first injection, but the appetite-reducing effects most people notice build gradually over days to weeks. Clinical trial data show that meaningful weight loss typically emerges across the first four to eight weeks, with the greatest changes coming at higher maintenance doses reached over months. These are prescription-only medicines; a prescriber assesses your suitability before treatment begins. If you have questions about how tirzepatide works at a pharmacological level, our guide to the mechanism behind the Mounjaro injection covers the science in detail.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
After a subcutaneous injection into the abdomen, thigh or upper arm, tirzepatide is absorbed gradually from the tissue. Its half-life is approximately five days, which is why once-weekly dosing maintains a steady level in the bloodstream. Peak plasma concentration arrives roughly 24–72 hours post-injection, according to the product's Summary of Product Characteristics published on the eMC. During that window, the medicine is most actively engaging both the GIP and GLP-1 receptors involved in appetite regulation and gastric motility. Practically speaking, this means the days immediately following your weekly injection tend to be when appetite suppression is most pronounced, and that effect tapers slightly toward the end of the week before the next dose.
Slowed gastric emptying — food leaving the stomach more gradually — contributes to earlier fullness and begins with the first dose. If you want a detailed breakdown of how long after injecting Mounjaro it takes to work, including what to expect in those first 24 to 72 hours, that page walks through the timeline stage by stage. Others take a couple of weeks. Both experiences sit well within the range reported in trial populations. The tirzepatide injection overview covers administration technique and storage if you are preparing for your first pen.
The 2.5 mg starting dose exists to allow your system to adjust, particularly your gut, before the therapeutic dose is reached. It is a tolerability step rather than the treatment's full effect. Titration through 5 mg, 7.5 mg and beyond brings progressively stronger receptor engagement, and the appetite changes deepen accordingly. In SURMOUNT-1, published in the New England Journal of Medicine, participants on 15 mg tirzepatide achieved an average body-weight reduction of around 20–21% over 72 weeks, but those changes accumulated across the full trial period rather than arriving in the first month. The early weeks are often described by our clinical team as the adjustment phase: the medicine is working, your body is responding, but the numbers on the scale catch up later.
A question our prescribers hear regularly is whether a lack of dramatic change in week one means something has gone wrong. It has not. The steady accumulation of effect across the titration schedule is the intended pharmacological pattern, not a failure. If you are curious about how soon Mounjaro works after injection, including why the response in week one differs from later in the titration schedule, that page goes into the detail. If you are curious about how the timeline differs from week to week, the page on how long after the first injection Mounjaro starts to work addresses that early period specifically.
For many people, the first signal that tirzepatide is active is gastrointestinal: nausea, a reduced desire to eat, or mild digestive discomfort, particularly in the days after injecting. These effects are a direct consequence of slowed gastric emptying and GLP-1 receptor activity. They are most common after starting the medicine or stepping up a dose, and they generally ease within a week or two as the body adjusts. The NHS tirzepatide information page lists the common side effects and the circumstances in which you should seek medical advice promptly, including severe or persistent abdominal pain radiating to the back, which warrants urgent attention.
Keeping injection day consistent (the same day each week) helps maintain the steadiest possible drug level. Plenty of people pick a weekday morning, set a reminder, and treat it like any other weekly routine. The pen goes back in the fridge door afterwards, and that is genuinely the full process once technique is established. For side-effect management, the Patient Information Leaflet that comes with every pen should be your first reference; our prescribers are also available through aftercare if something concerns you. You can find contact options on the support page.
Putting the evidence together, a practical picture emerges. Pharmacological activity: within hours. Noticeable appetite change: days one to fourteen for most people. First measurable weight-loss signal: often weeks two to four. Meaningful, visible change: typically by months two to three. Peak effect at the highest tolerated dose: built across six to twelve months of continued treatment, consistent with the 72-week SURMOUNT-1 trial framework. Individual variation is real, shaped by starting weight, diet, activity, metabolic profile and the dose reached.
These timelines matter when you are deciding whether the treatment is right for you. A prescriber reviews not just eligibility but the whole clinical picture, which is why the consultation is the starting point rather than an administrative step. If you are weighing up the cost of private treatment alongside the clinical question, the context around Mounjaro pricing in the UK is worth reading before committing. When you are ready to talk to a clinician, you can start your free consultation with our prescribers and have your questions answered the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.